Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression - Wikidata - wikimedia - TriplyDB

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression

http://www.wikidata.org/entity/Q34154244

about

Secukinumab for rheumatology: development and its potential place in therapy Secukinumab: A New Treatment Option for Psoriatic Arthritis Secukinumab for ankylosing spondylitis and psoriatic arthritis An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled perio Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype.Bone-immune cell crosstalk: bone diseases.Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses.TNF Blockade Maintains an IL-10+ Phenotype in Human Effector CD4+ and CD8+ T Cells Mechanistic rationales for targeting interleukin-17A in spondyloarthritis.Biomarkers in psoriatic arthritis: recent progress.Tc17 Cells in Immunity and Systemic Autoimmunity.IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.The IL-23-IL-17 axis in inflammatory arthritis.Mediators of inflammation and bone remodeling in rheumatic disease.Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis.The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease.Secukinumab: A Review in Psoriatic Arthritis.Targeting IL-17 in autoimmunity and inflammation.The role of IL 23 in the treatment of psoriasis.Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints.Susceptibility to chronic inflammation: an update.The role of IL-17 in the treatment of psoriatic arthritis.Arthritis is developed in Borrelia-primed and -infected mice deficient of interleukin-17.Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spond Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis.Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.CD4 T-Cell Dysregulation in Psoriatic Arthritis Reveals a Regulatory Role for IL-22.Targeting IL-17 in psoriatic arthritis.A Review of the Use of Secukinumab for Psoriatic Arthritis.Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis.Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review.The spectrum of psoriatic arthritis in a South African cohort.Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.CXCL4 is a novel inducer of human Th17 cells and correlates with IL-17 and IL-22 in psoriatic arthritis.

P2860

Q26738523-F2490994-2FFF-46A5-B7C6-DBF82560E814 Q28066204-A34C568D-7DB0-4381-BADB-ED3024D90595 Q28071474-E6C14034-7D15-45ED-858B-23BADE283E0D Q28077367-E08884C0-CBF2-402C-BE9F-CDE10A131786 Q30407889-24350324-CBFC-4C6D-B44E-2722E485BF0C Q34538249-719FCB49-4080-4E97-AAB9-94833523A981 Q34550631-71212F52-CDD5-40E2-A23D-D138F53E89A2 Q35577152-50F2594F-E038-4A1E-AA0C-D7189E7325E2 Q35592362-80012CCB-6D26-443B-A20B-8F3EC33488AA Q36369917-68599E54-3EBE-4504-8136-B6DABB18581F Q37272441-FFC64485-135F-4C18-BCC3-B520E475F8AF Q37642265-35E28487-5B20-48C4-AF0F-75157A0FBD5A Q37686009-EB2A66AA-8D13-46C2-956C-A081BEC6E926 Q38248904-C403AD67-29CA-4594-9DD7-FE624EE360C6 Q38254602-3C6D5210-C3A9-4E13-9554-3CED162CD3EB Q38328539-B489268D-3105-47FC-9629-4CEBD783FAE1 Q38431361-2CDA9B23-64B0-4856-A976-5ACC3E2F07C0 Q38439641-ABD30B6F-F33D-4D37-9252-4D501AEDD4BF Q38576851-03A3CD38-5B73-40F7-A2A9-D0FB9C12A529 Q38664951-444C0193-387D-463B-9340-C2C986E31327 Q38815070-37D480B4-7154-412C-AFA2-AF2E9F02FDDB Q38833064-1D703BC9-E532-405C-ADDB-FEED082C011A Q38864743-856FCC51-3CB4-433C-9773-06098BF7138F Q38941407-195AE826-A562-49E1-BA5A-38BAAA589310 Q38976762-2806D44A-E306-4362-9C2A-6FB0542756C4 Q39084926-49148500-1393-43F5-9B93-C4AABD6250F4 Q39107170-D1EF7E71-9309-459F-9EE9-C1E4D7C4CB19 Q39293096-5D7A7CB9-0971-485F-8754-1A3CB066E208 Q40587751-819B156C-E5C5-4128-AAD5-3AAC56C4ED47 Q40722205-8C705EEE-3D49-4E7D-A933-A7B497E1B301 Q40740817-86715A03-1C66-477D-8CA2-D79D7BBCC9B8 Q41449533-9868A707-8C1B-4172-82F0-3D3E21E04289 Q45795234-E9C85723-5663-40C0-8EBC-175F2FBB49FC Q47140713-F481CFCA-7C92-4BCF-93C8-F9552E4FD1DE Q47160133-B6F87689-106C-4695-B6ED-2F51D03EAABC Q47577398-FC5C3EE1-0889-4C25-B18C-984F15A65CD1 Q47584168-3146FE6B-F41D-4D5D-8227-91B03EAAF49E Q47637987-0F9F5AE7-0041-4D5B-BABD-6EFB5C5C6F03 Q47696280-54C036F1-5967-4990-BF7C-621ED33820FB Q48203983-F89D038C-A385-4B4D-A5EE-8FCC938ABE59

P2860

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression

http://www.wikidata.org/entity/Q34154244

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@ast

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@en

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@nl

type

label

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@ast

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@en

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@nl

prefLabel

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@ast

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@en

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@nl

P1433

Q34154244-61780471-F3F2-473C-9F1A-F365A37F7CBF

P1476

Q34154244-D114005B-D82B-4432-8321-717E66A86ECA

P2093

Q34154244-40DF047C-FBE9-4252-A822-57CA9CEBB608

Q34154244-68C2168A-BEF6-40C7-AC5D-EBF46971CB86

Q34154244-81FABE5C-0A75-40BF-BA0B-70E1A29C6CE1

Q34154244-A521411E-0928-4200-8D79-356682B588C7

Q34154244-EA43815B-E9EA-4977-8D5C-190E3B7C78CD

Q34154244-F31FA737-6DAD-4510-8E18-FEAF54D41500

P2860

Q34154244-02F88156-3C3E-4D12-A71F-BE416E208B98

Q34154244-03522B39-FE05-46A5-9714-A410301464DA

Q34154244-0F8A140D-39EB-4DE1-98A2-06F985366A2D

Q34154244-13E70F83-A734-40BD-B21E-E7CB6EA9F1ED

Q34154244-2A2033B0-0CFD-4901-8D1C-DBEE0BD7F40C

Q34154244-3F852AE7-D3CF-44E1-BC16-A9496CF2C87A

Q34154244-429B86B0-97C7-458B-9F3C-376CD7981229

Q34154244-48C37F1C-DCDC-4C5C-AE3E-7BD8A7E20ED8

Q34154244-4B35E462-3829-4D66-93B5-74E65C2DC732

Q34154244-4DD24866-8D99-4945-8E7C-64DAE140FFE2

P304

Q34154244-A2FFEE71-7F42-44D1-8A65-A81E09EEE9E1

P31

Q34154244-446D6C3D-9D45-428B-93DF-A7C72E23DC6A

P356

Q34154244-F92D9454-F2ED-4E03-A89D-2A4C2DA74266

P433

Q34154244-0E0DB7CF-C2E5-4B5B-872F-9E126CD7CB70

P478

Q34154244-186BA78B-11E3-4607-ABE0-F2423DC61A17

P50

Q34154244-0291E379-F74C-4449-A5B9-A0B69589B464

Q34154244-13280836-5918-46B8-92F4-20944C5AC34D

P577

Q34154244-54E90A1B-EFC6-4E5B-AE61-14D9AF608C04

P5875

Q34154244-BDF14F2A-35A7-4F6C-A389-A8C95DCB27FD

P698

Q34154244-9054E59E-2669-4D20-9300-12005F5C42B4

P921

Q34154244-58d69ed5-b945-4fab-aef0-b5a1bbbaff9c

Q34154244-D1DADD82-B0BF-4556-B104-98CAB8A2E111

P932

Q34154244-32D3D3EC-C060-47D6-B84E-DBFD38E0AE45

P356

P1433

Arthritis & Rheumatology

P1476

Interleukin-17+CD8+ T cells ar ...... y and joint damage progression

@en

P2093

Bina Menon

http://www.w3.org/2001/XMLSchema#string

Bruce W Kirkham

http://www.w3.org/2001/XMLSchema#string

Gina J Walter

http://www.w3.org/2001/XMLSchema#string

Hayley G Evans

http://www.w3.org/2001/XMLSchema#string

Megha Rajasekhar

http://www.w3.org/2001/XMLSchema#string

Toby Garrood

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

Interleukin-17 and type 17 helper T cells

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis

Psoriatic arthritis in Sub-Saharan Africa.

Innate IL-17-producing cells: the sentinels of the immune system.

Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint

Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.

Psoriasis--epidemiology and clinical spectrum.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

P304

1272-1281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.38376

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Leonie S. Taams

Nicola J Gullick

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259957416

http://www.w3.org/2001/XMLSchema#string

P698

24470327

http://www.w3.org/2001/XMLSchema#string

P921

P932

4158887

http://www.w3.org/2001/XMLSchema#string